IL17A and stroke disorder: Studies demonstrate that blocking γδ T cells, IL-17a, or IL-21 confers significant neuroprotective effects against ischemic brain injury in murine stroke models, establishing them as promising therapeutic targets for mitigating ischemic brain damage (109, 193).